Employment without Challenge - Executive Professional Representative Merck Employee Review

3.0
Apr 2, 2013
Recommend
CEO approval
Business Outlook

Pros

1. Pay able to provide for the family 2. Benefits 3. Time off 4. Adequacy of flexibility of management with regards to time off.

Cons

1. Lack of growth and career development 2. Prevailing stated attitude that every employee is "responsible for their own career" and then have to run things by management just to POST for a job. 3. Old technology - very old 4. Management is protected like they are infallible. Many of the managers are misplaced and only swallow the corporate jargon. They are maintainers not innovators or even motivators. 5. Communication is weak. Management claims transparency and then lays off entire departments. Needs to improve. 6. Culture of reprisal. Merck claims to encourage, "Courage and Candor," but employees are told on a regular basis that how they communicate is disfavored. Only serves to have a chilling effect on "courage and candor." 7. Learn that quality of work and performance reviews is not how to get ahead EARLY. Get plugged in, have lunch with many different people, have many different mentors, if permitted get on as many different projects as you can. Being intelligent, hard-working, and ambitious is not enough. You also must be best-friends with hiring managers to advance.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All